Placebo Response in Cluster Headache Trials: A Review
- 1 September 2003
- journal article
- review article
- Published by SAGE Publications in Cephalalgia
- Vol. 23 (7) , 504-510
Abstract
Probably because of its relative rarity as primary headache, there are few well-controlled clinical trials on cluster headache (CH) patients. Due to the severity of the pain, the placebo response in CH has been considered to be small. During the eighties the first double-blind, placebo-controlled trials were reported, and placebo responses demonstrated. Here we review the placebo response in CH trials in order to assess its magnitude and consider how future studies can be optimized. Six trials were identified with a double-blind, placebo-controlled, cross-over design testing treatments of acute CH. For those with a primary endpoint set to no or mild headache the placebo responses varied from 7 to 42%. In five of seven prophylactic trials, using a double-blind, placebo-controlled, parallel-group design, the placebo was merely used to set a baseline for comparison. The placebo responses were reported in only two trials. Here the response varies from 14 to 43%, the lowest value was reported using the strict endpoint; cessation of headache attacks. We conclude that a placebo response exists in trials of drugs on CH patients. Furthermore, this placebo response is of the same magnitude as that seen in migraine studies. We recommend the use of IHS guidelines when designing new trials. The possibility of a genuine biological mechanism responsible for the placebo response is discussed.Keywords
This publication has 27 references indexed in Scilit:
- Oral zolmitriptan is effective in the acute treatment of cluster headacheNeurology, 2000
- Verapamil in the prophylaxis of episodic cluster headache: A double-blind study versus placeboNeurology, 2000
- Double-Blind Placebo-Controlled Trial of Lithium in Episodic Cluster HeadacheCephalalgia, 1997
- Melatonin Versus Placebo in the Prophylaxis of Cluster HeadacheCephalalgia, 1996
- Preemptive Oral Treatment With Sumatriptan During a Cluster PeriodHeadache: The Journal of Head and Face Pain, 1995
- A Double-Blind Placebo-Controlled Trial of Intranasal Capsaicin for Cluster HeadacheCephalalgia, 1993
- Treatment of Acute Cluster Headache with SumatriptanNew England Journal of Medicine, 1991
- Dihydroergotamine Nasal Spray in the Treatment Of Attacks of Cluster Headache: A Double-Blind Trial Versus PlaceboCephalalgia, 1986
- Treatment of Cluster HeadacheArchives of Neurology, 1985
- Methodological Aspects of Prophylactic Drug Trials in MigraineCephalalgia, 1981